Red blood cell Much of this potential appears to be contributed by the exposed sialic acid residues in the membrane: their removal results in zeta potential of −6.06 mV. When red blood cells undergo shear stress in constricted vessels, they release ATP, which causes the vessel walls to relax and dilate so as to promote normal blood flow. When their hemoglobin molecules are deoxygenated, red blood cells release S-nitrosothiols, which also act to dilate blood vessels, thus directing more blood to areas of the body depleted of oxygen. Red blood cells can also synthesize nitric oxide enzymatically, using L-arginine as substrate, as do
Genetically engineered blood Genetically engineered blood Genetically engineered blood is blood that has been modified for therapeutic or other purposes. Genetically modifying red blood stem cells allows them to produce specific therapeutic proteins on the surface or inside the cell. The stem cells are taken from mammalian bone marrow and are modified in culture. Before they become mature, mammalian red blood cells eject their genetic material. Culturing cells that produce a new protein of interest requires only a few weeks. Using the sortagging protein labeling technique, the researchers used the bacterial enzyme sortase A to establish a strong chemical bond between the surface